Commentary on Banham & Gilbody (2010): The scandal of smoking and mental illness

Addiction

Volumn 105, Issue 7, 2010, Pages 1190-1191

  Stapleton, John A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Mental illness; Smoking; Treatment

Indexed keywords

HEALTH CARE DISPARITY; HUMAN; MENTAL DISEASE; NOTE; SMOKING;

HEALTHCARE DISPARITIES; HUMANS; MENTAL DISORDERS; SMOKING;

EID: 77953317344     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03025.x     Document Type: Note

References (18)

1. Banham L., Gilbody S. Smoking cessation in severe mental illness: what works? Addiction 2010 105 : 1176 1189.
2. de Leon J., Diaz F. J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005 76 : 135 157.
3. Williams J. M., Ziedonis D. M., Abanyie F., Steinberga M. L., Foulds J., Benowitz N. L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 2005 79 : 323 335.
4. Strand J.-E., Nybäck H. B. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur Psychiatry 2005 20 : 50 4.
5. Weinberger A. H., Reutenauer E. L., Allen T. M., Termine A., Vessicchio J. C., Sacco K. A. et al. Reliability of the Fagerstrom Test for Nicotine dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for smoking urges in smokers with and without schizophrenia. Drug Alcohol Depend 2007 86 : 278 282.
6. Rabin R. A., Sacco K. A., George T. P. Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status. Schizophr Res 2009 114 : 91 7.
7. Tidey J. W., Rohsenow D. J., Kaplan G. B., Swift R. M. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend 2005 80 : 259 265.
8. Barr A. M., Procyshyn R. M., Hui P., Johnson J. L., Honer W. G. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophr Res 2008 100 : 252 260.
9. Prochaska J. J., Leek D. N., Hall S. E., Hall S. M. Cognitive interviews for measurement evaluation of the Fagerström Test for Nicotine Dependence (FTND) in smokers with schizophrenia spectrum disorders. Addict Behav 2007 32 : 793 802.
10. Colton C. W., Manderscheid R. W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006 3 : A42.
11. Miller B. J., Paschall C. B. III., Svendsen D. P. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv 2006 57 : 1482 1487.
12. Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatr Serv 1998 49 : 925 928. (Pubitemid 28311521)
13. Fagerström K., Aubin H. J. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin 2009 25 : 511 518.
14. Hall S. M., Prochaska J. J. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol 2009 5 : 409 431.
15. Chapman S., MacKenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 2010 7 : e1000216.
16. Department of Health. 2010 http://smokefree.nhs.uk/ (accessed 26 April 2010).
17. Stapleton J. A., Watson L., Spirling L. I., Smith R., Milbrandt A., Ratcliffe M. et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 2008 103 : 146 154.
18. Gunnell D., Irvine D., Wise L., Davies C., Martin R. M. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ 2009 339 : b3805 doi:10.1136/bmj.b3805.